The new patent expands coverage for certain ANAVEX 2-73 crystal forms preparatio...
The deal amount includes an initial $107.17m cash consideration and an additiona...
Rentschler’s ATMP site in Stevenage will undertake bioprocess development of AAV...
Funding will be used to support the company’s platform based on Nobel Prize winn...
To clarify the PA role and disambiguate us from physicians, PAs must adopt a new...
As with just about everything else — school, employment, housing, friends — heal...
An insurer backs off from new barriers to colonoscopies, but imposes new incenti...
Algorithms that adjust for race raise the threshold for diagnosing a problem in ...
Why are fake medical devices more lucrative than real ones? Is Ozempic a neurolo...
In the latest edition of STAT's Health Tech newsletter: Nuance's mysterious pric...
A study of thousands of people who were prescribed GLP-based drugs like Ozempic ...
U.S. births were flat last year, as the nation saw fewer babies born than it did...
Despite pressure from Congress and advocates, CMS isn’t changing its coverage pl...
Coherus BioSciences plans to sell a Humira biosimilar at a steep discount and wi...
Tempus, a company that combines DNA sequencing for cancer with artificial intell...
In a bold move, Coherus BioSciences plans to sell a Humira biosimilar at a steep...
